Nov 12, 2018 4:45pm EST DiaMedica Therapeutics Has Applied to List its Common Shares on Nasdaq, Announces Share Consolidation
Nov 06, 2018 5:00pm EST DiaMedica Therapeutics Announces Results From Annual General and Special Meeting of Shareholders
Sep 27, 2018 7:38am EDT DiaMedica Therapeutics and Ahon Pharma, a Fosun Pharma Portfolio Company, Announces Signing of License Agreement for DM199 in China for Acute Ischemic Stroke
Sep 05, 2018 8:00am EDT DiaMedica Therapeutics Announces the Appointment of Dr. Harry Alcorn Jr. as Chief Medical Officer
May 03, 2018 8:30am EDT DiaMedica Announces Positive Results From FDA Meeting on Planned Clinical Trial in Patients with Chronic Kidney Disease
Apr 05, 2018 7:15am EDT DiaMedica Therapeutics Announces Appointment of Scott Kellen as Chief Financial Officer
Apr 04, 2018 4:00pm EDT DiaMedica to Present at the MicroCap Conference on April 10th in New York City at the Essex House
